Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Issues reported with supply of lactating cow intramammary antibiotics
Ubro Yellow Milking Cow Intramammary Suspension is one of the products to be suspended.

VMD updates list of available products

The Veterinary Medicines Directorate (VMD) has reported supply problems with certain lactating cow intramammary antibiotics.

The following is a list of lactating cow intramammary antibiotics that Marketing Authorisation Holders (MAHs) have noted availability problems for, along with anticipated resolution dates for each product:

Product Anticipated resolution date
Synulox Lactating Cow Intramammary Suspension (42058/4143) First quarter of 2021
Tetra-Delta Intramammary Suspension (42058/4152) First half of 2021
Ubro Yellow Milking Cow Intramammary Suspension (08327/4305) Product discontinued – no return date
Multiject IMM Intramammary Suspension (02000/4062) February 2021
Albiotic 330mg/100mg Intramammary Solution (30282/4035) December 2020
Mastiplan LC, 300mg/20mg Intramammary Suspension (01708/4534) End of November 2020
Cobactan MC Intramammary Suspension for Lactating Cows (01708/4444)* December 2020
Combiclav Intramammary Suspension for Lactating Cows (02000/4424) January 2021
Cefimam LC, 75 mg Intramammary Ointment for Lactating Cows (02000/4387)* product discontinued – no return date

These lactating cow intramammary products have been reported as available for veterinary surgeons to purchase:

Ubropen 600 mg Intramammary Suspension for Lactating Cows (42810/4000)
Ubrolexin Intramammary Suspension for Lactating Dairy Cows (08327/4306)
Procapen Injector 3g intramammary suspension for cattle (24745/4023)
Orbenin L.A. 200mg Intramammary Suspension (42058/4090)
Pathocef 250mg Intramammary Suspension (42058/4094)*

Please note: VMD states that the products marked with a '*' are defined as a Highest Priority Critically Important Antibiotics for human medicine and, under the Red Tractor farm assurance scheme for beef and dairy, should be used as a last resort and supported by sensitivity and/or diagnostic testing.

For further details of the supply situation for individual UK-authorised products, please contact the MAH or a wholesale dealer.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'